05May/14

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart … – TCTMD

REMINDER Study: Eplerenone Safe, Effective in STEMI Patients Without Heart
TCTMD
Eplerenone, a mineralocorticoid receptor antagonist, is typically used for the treatment of chronic heart failure (HF). For the study, Gilles Montalescot, MD, PhD, of the Centre Hospitalier Pitié-Salpêtrière (Paris, France), and colleagues randomized 1
CardioNotes: STEMI Tx, Kids’ Cholesterol, Bystander CPRMedPage Today

all 2 news articles »

05May/14

Breathe right – Livemint

LivemintBreathe rightLivemintAbout 100-150 million people around the globe, 15-20 million of them in India, suffer from asthma, according to the World Health Organization (WHO). A 2012 report published in the International Journal Of Tuberculosis And L…